Zusammenfassung
Im Zuge der fortschreitenden Globalisierung der Wirtschaft und des Außenhandels wurde die Forderung nach Harmonisierung der gesetzlichen Anforderungen und Praktiken für Medizinprodukte erhoben. Aufgabe der Globalen Arbeitsgruppe für Harmonisierung (GHTF) ist die Förderung der Konvergenz regulatorischer Vorschriften und Praktiken auf globaler Ebene durch Konsens, um die folgenden vier Hauptziele zu erreichen: Verbesserung der Sicherheit, Qualität und Leistung von Medizinprodukten; Förderung technologischer Innovation und des internationalen Handels; Bildung eines Forums für Informationsaustausch – alles im Interesse der Förderung und des Schutzes der öffentlichen Gesundheit. Die Lenkung der GHTF liegt in den Händen des Lenkungsausschusses, und die grundsätzliche Entwicklung des GHTF-Vorschriftenmodells ist und bleibt in den Händen von fünf Arbeitsgruppen, die Studiengruppen genannt werden. Sie sind in jüngster Zeit durch die Bildung mehrerer Ad-hoc-Arbeitsgruppen ergänzt worden. Seit Gründung der GHTF im Jahre 1992 haben ihre Mitglieder gemeinsam daran gearbeitet, ein Konzept zu schaffen, das nun so weit fortgeschritten ist, dass es als ein globales Vorschriftenmodell für Medizinprodukte bezeichnet werden kann.
Abstract
With the move towards globalized international commerce and trade, a call for harmonization of medical device regulatory requirements and practices has evolved. The purpose of the Global Harmonization Task Force (GHTF) is to encourage convergence of regulatory requirements and practices at a global level through consensus to achieve four principle goals: promote safety, quality and performance/effectiveness of medical devices; encourage technological innovation; foster international trade; and serve as a forum of information exchange – all in the interests of protecting and promoting public health. The GHTF is governed by a Steering Committee, and the principle development of the GHTF regulatory model has been, and continues to be, done through five working groups known as Study Groups and supplemented recently by the creation of several Ad Hoc Working Groups. Since its creation in 1992, the members of the GHTF have worked collaboratively to develop what is now ready to be called a global model for the regulation of medical devices.
Literatur
Global Harmonization Task Force Website (n d) http://www.ghtf.org
Global Harmonization Task Force Steering Committee (2008) GHTF roles roles responsibilities. SC-N2R10:2008, 20 p. http://www.ghtf.org
United States and Canadian Delegations to the GHTF (2007) Action plan for 2007–2010. Path forward for the global harmonization Task Force, 8 p. http://www.ghtf.org
Global Harmonization Task Force Study Group 1 (2006) Principles of medical devices classification. SG1-N15:2006, 27 p. http://www.ghtf.org
Global Harmonization Task Force Steering Committee (2007) Definition and glossary of terms used in GHTF documents (Draft), 21 p. http://www.ghtf.org
Global Harmonization Task Force Study Group 5 (2007) Clinical evidence – key definitions and concepts. SG5/N1R8:2007, 8 p. http://www.ghtf.org
Global Harmonization Task Force Study Group 1 (2008) Summary technical documentation for demonstrating conformity to the essential principles of safety and performance of medical devices (STED). SG1-N11:2008, 21 p. http://www.ghtf.org
Global Harmonization Task Force Study Group 1 (2005) Essential principles of safety & performance of medical devices. SG1-N41R9:2005, 16 p. http://www.ghtf.org
Global Harmonization Task Force Study Group 1 (2006) Principles of conformity assessment for medical devices. SG1-N40:2006, 16 p. http://www.ghtf.org
Global Harmonization Task Force Study Group 5 (2007) Clinical evaluation. SG5/N2R8:2007, 28 p. http://www.ghtf.org
Global Harmonization Task Force Study Group 3 (2008) Quality management system – medical devices – guidance on the control of products and services obtained from suppliers. SG3-N17:2008, 21 p. http://www.ghtf.org
Global Harmonization Task Force Study Group 3 (2005) Implementation of risk management principles and activities within a quality management system. SG3-N15R8:2005, 23 p. http://www.ghtf.org
Global Harmonization Task Force Study Group 4 (2008) Guidelines for regulatory auditing of quality management systems of medical device manufacturers – Part 1: General requirements. SG4-N28R4:2008, 36 p. http://www.ghtf.org
Global Harmonization Task Force Study Group 4 (2006) Guidelines for regulatory auditing of quality management systems of medical devices manufacturers – Part 2: Regulatory auditing strategy. SG4/N30R20:2006, 33 p. http://www.ghtf.org
Global Harmonization Task Force Study Group 4 (2007) Guidelines for regulatory auditing of quality management systems of medical device manufacturers – Part 3: Regulatory audit reports. SG4-N33R16:2007, 11 p. http://www.ghtf.org
Global Harmonization Task Force Study Group 1 (2008) Role of standards in the assessment of medical devices. SG1-N44:2008, 10 p. http://www.ghtf.org
Global Harmonization Task Force Study Group 2 (2006) Medical devices post market surveillance: global guidance for adverse event reporting for medical devices. SG2-N54R8:2006, 37 p. http://www.ghtf.org
Global Harmonization Task Force Study Group 2 (2000) Guidance on how to handle information concerning vigilance reporting related to medical devices. SG2-N8R4, 6 p. http://www.ghtf.org
Global Harmonization Task Force Study Group 2 (2006) Medical devices: post market surveillance: national competent authority report exchange criteria and report form. SG2-N79R8:2006, 13 p. http://www.ghtf.org
Global Harmonization Task Force Study Group 2 (2005) Application requirements for participation in the GHTF national competent authority report exchange program. SG2/N38R15, 9 p. http://www.ghtf.org
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rotter, R. Die Global Harmonization Task Force. Bundesgesundheitsbl. 52, 601–604 (2009). https://doi.org/10.1007/s00103-009-0858-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00103-009-0858-9